566 related articles for article (PubMed ID: 23476052)
21. [Importance of HLA in Determining Individual Differences in the Onset of Adverse Drug Reactions].
Aoki S
Yakugaku Zasshi; 2021; 141(8):1001-1007. PubMed ID: 34334545
[TBL] [Abstract][Full Text] [Related]
22. Pathogenesis of drug allergy--current concepts and recent insights.
Schnyder B; Brockow K
Clin Exp Allergy; 2015 Sep; 45(9):1376-83. PubMed ID: 26172398
[TBL] [Abstract][Full Text] [Related]
23. Bioactivation of drugs in the skin: relationship to cutaneous adverse drug reactions.
Sharma AM; Uetrecht J
Drug Metab Rev; 2014 Feb; 46(1):1-18. PubMed ID: 24164504
[TBL] [Abstract][Full Text] [Related]
24. In vitro testing for diagnosis of idiosyncratic adverse drug reactions: Implications for pathophysiology.
Elzagallaai AA; Rieder MJ
Br J Clin Pharmacol; 2015 Oct; 80(4):889-900. PubMed ID: 25199801
[TBL] [Abstract][Full Text] [Related]
25. Idiosyncratic Drug-Induced Liver Injury: Mechanistic and Clinical Challenges.
Jee A; Sernoskie SC; Uetrecht J
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799477
[TBL] [Abstract][Full Text] [Related]
26. Are drug metabolites able to cause T-cell-mediated hypersensitivity reactions?
Sullivan A; Gibson A; Park BK; Naisbitt DJ
Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):357-68. PubMed ID: 25495340
[TBL] [Abstract][Full Text] [Related]
27. Immune pathomechanism of drug hypersensitivity reactions.
Pichler WJ; Naisbitt DJ; Park BK
J Allergy Clin Immunol; 2011 Mar; 127(3 Suppl):S74-81. PubMed ID: 21354503
[TBL] [Abstract][Full Text] [Related]
28. The importance of hapten-protein complex formation in the development of drug allergy.
Faulkner L; Meng X; Park BK; Naisbitt DJ
Curr Opin Allergy Clin Immunol; 2014 Aug; 14(4):293-300. PubMed ID: 24936850
[TBL] [Abstract][Full Text] [Related]
29. Delayed drug hypersensitivity: models of T-cell stimulation.
Adam J; Pichler WJ; Yerly D
Br J Clin Pharmacol; 2011 May; 71(5):701-7. PubMed ID: 21480949
[TBL] [Abstract][Full Text] [Related]
30. Immune mechanisms in drug allergy.
Roujeau JC
Allergol Int; 2006 Mar; 55(1):27-33. PubMed ID: 17075283
[TBL] [Abstract][Full Text] [Related]
31. Nonimmediate reactions to betalactams.
Lopez S; Blanca-Lopez N; Cornejo-Garcia JA; Canto G; Torres MJ; Mayorga C; Blanca M
Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):310-6. PubMed ID: 17620822
[TBL] [Abstract][Full Text] [Related]
32. Allergic reactions to antibiotics, mainly betalactams: facts and controversies.
Viola M; Quaratino D; Gaeta F; Valluzzi RL; Caruso C; Rumi G; Romano A
Eur Ann Allergy Clin Immunol; 2005 Jun; 37(6):223-9. PubMed ID: 16156401
[TBL] [Abstract][Full Text] [Related]
33. The use of PD-1 functional knockout rats to study idiosyncratic adverse reactions to nevirapine.
Cho T; Hayes A; Henderson JT; Uetrecht J
Toxicol Sci; 2024 May; ():. PubMed ID: 38767978
[TBL] [Abstract][Full Text] [Related]
34. Molecular docking to identify associations between drugs and class I human leukocyte antigens for predicting idiosyncratic drug reactions.
Luo H; Du T; Zhou P; Yang L; Mei H; Ng H; Zhang W; Shu M; Tong W; Shi L; Mendrick DL; Hong H
Comb Chem High Throughput Screen; 2015; 18(3):296-304. PubMed ID: 25747444
[TBL] [Abstract][Full Text] [Related]
35. An Animal Model of Abacavir-Induced HLA-Mediated Liver Injury.
Song B; Aoki S; Liu C; Susukida T; Ito K
Toxicol Sci; 2018 Apr; 162(2):713-723. PubMed ID: 29319822
[TBL] [Abstract][Full Text] [Related]
36. The role of haptic macrophages in regulation of idiosyncratic drug reactions.
Ju C
Toxicol Pathol; 2009 Jan; 37(1):12-7. PubMed ID: 19171927
[TBL] [Abstract][Full Text] [Related]
37. Noncovalent interactions of drugs with immune receptors may mediate drug-induced hypersensitivity reactions.
Gerber BO; Pichler WJ
AAPS J; 2006 Mar; 8(1):E160-5. PubMed ID: 16584124
[TBL] [Abstract][Full Text] [Related]
38. Genetics and the potential for predictive tests in adverse drug reactions.
Pirmohamed M
Chem Immunol Allergy; 2012; 97():18-31. PubMed ID: 22613851
[TBL] [Abstract][Full Text] [Related]
39. [The associations between idiosyncratic adverse drug reactions and HLA alleles and their underlying mechanism].
Wang Q; Mei H; Zhang YL; Pan XC; Tan W; Chao L
Yao Xue Xue Bao; 2013 Jun; 48(6):799-808. PubMed ID: 23984511
[TBL] [Abstract][Full Text] [Related]
40. Screening for the potential of a drug candidate to cause idiosyncratic drug reactions.
Uetrecht J
Drug Discov Today; 2003 Sep; 8(18):832-7. PubMed ID: 12963319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
